The Quantellect read.As of Nov 19, 2026, 10 active firms cover Elanco Animal Health: 9 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $26.00 to $33.00, so the covering firms are broadly aligned. The average target of $30.40 sits 14% above the current $26.69. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.44 next quarter toward $1.29 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 active firms
Buy
Strong Buy00%
Buy990%
Neutral110%
Sell00%
Strong Sell00%
Based on 10 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$30.40
+13.9% upside
Average target across 10 active firms as of Nov 19, 2026 vs $26.69 current
Highest Target$33.00
Average Target$30.40
Lowest Target$26.00
Detailed analyst forecasts for ELAN
Showing 1–10 of 10 named analysts shown · 10 active firms in the rating projection
As of Nov 19, 2026, 9 of 10 active firms rate ELAN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ELAN EPS & revenue forecast
EPS · NEXT QUARTER
$0.44
Range $0.42 – $0.46 · 8 analysts · +9% YoY
Next period, 8 analysts expect Elanco Animal Health to earn $0.44 a share (range $0.42 – $0.46), versus $0.40 a year earlier. Full-year consensus is $1.18, growing to $1.29 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.5B · 8 analysts · +4% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.5B), +4.3% year-over-year. Full-year consensus is $5.2B, rising to $5.4B next year.
Top analysts covering Elanco Animal Health
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ELAN.
#1
Erin Wright
Morgan Stanley · Rank #81
Neutral
$25.00-6.3% to target
Overall win rate
55%
+ Follow
#2
Balaji Prasad
Barclays · Rank #226
Buy
$19.00-28.8% to target
Overall win rate
45%
+ Follow
#3
CS
Chris Schott
JP Morgan · Rank #287
Buy
No targeton ELAN
Overall win rate
41%
+ Follow
#4
Jonathan Block
Stifel · Rank #294
Buy
No targeton ELAN
Overall win rate
36%
+ Follow
#5
David Westenberg
Piper Sandler · Rank #314
Buy
$30.00+12.4% to target
Overall win rate
35%
+ Follow
ELAN stock forecast FAQ
What is ELAN's average 12-month price target?+
The 10 active firms with a live target average $30.40 for Elanco Animal Health over the next 12 months, ranging from a $33.00 high to a $26.00 low, as of Nov 19, 2026.
Is ELAN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 10 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ELAN?+
The Street-high target is $33.00 (UBS), and the Street-low is $26.00 (Morgan Stanley). The average of all 10 active-firm targets is $30.40.
How many active Wall Street firms cover ELAN?+
10 active firms have a recognized rating on Elanco Animal Health as of Nov 19, 2026, and 10 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ELAN?+
Among analysts who currently cover ELAN, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #81). Their current call is Neutral with a $25.00 target.
What is Elanco Animal Health's projected EPS for next quarter?+
The consensus estimate is $0.44 per share (range $0.42 – $0.46) across 8 analysts. Full-year EPS is projected at $1.18, rising to $1.29 the following year.
How much revenue is Elanco Animal Health expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.5B). Full-year revenue is projected at $5.2B, growing to $5.4B next year.
Have analysts been upgrading or downgrading ELAN lately?+
As of Nov 19, 2026, 9 of 10 active firms rate ELAN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ELAN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.